Alimera Sciences Inc.
Industry
- Biotechnology
- Pharmaceuticals
- Drug Delivery
- Site Specific
- Controlled Release
- Specialty Pharmaceuticals
- Drug Delivery
- Medical Devices
- Implantable Devices
Latest on Alimera Sciences Inc.
Actuate Therapeutics, Inc. grossed $22.4m from its initial public offering of 2.8 million shares priced at $8 each in the 15th biopharmaceutical company IPO in the US in 2024. It was not the smallest
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly The Latest Pharma Company To Sign
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis Buys Cystinosis Gene Therapy F
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. JCR Signs Deal With Sumitomo On Izcargo